Management of patients on the waiting list for deceased donor kidney transplantation

Myung-Gyu Kim, H. Ro, Y. J. Kim, H. C. Park, J. C. Jeong, H. J. Jeon, H. Kim, M. W. Park, K. H. Oh, Y. S. Kim, C. Ahn, J. Yang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Although the number of wait-listed patients for deceased donor kidney transplantation has been continuously increasing in Korea, no standard guidelines exist for their management. Methods: We retrospectively analyzed the medical records of our 1,231 wait-listed patients between 2000 and 2010. Results: The time to transplantation of the 201 recipients was 51.9 ± 31.2 months. Ninety-seven patients died while waiting. Diabetic or older patients have increased among new registrants; however, <50% of them have undergone regular screening for malignancy or cardiovascular diseases. Patients with regular screening were more likely to get a chance to receive a transplant (P =.016). Malignancy was newly diagnosed in 26 patients (2.1%) and reversible cardiac ischemia was detected in 9.7%. The presence of anti-HLA antibodies was strongly associated with a lower transplantation rate, whereas blood type O was not. Although use of expanded criteria donor (ECD) kidneys increased, many patients avoided them. Conclusion: It is necessary to improve management programs for wait-listed patients by establishing comorbidity screening and ECD education.

Original languageEnglish
Pages (from-to)66-71
Number of pages6
JournalTransplantation Proceedings
Volume44
Issue number1
DOIs
Publication statusPublished - 2012 Jan 1
Externally publishedYes

Fingerprint

Waiting Lists
Kidney Transplantation
Tissue Donors
Transplantation
Korea
Medical Records
Comorbidity
Anti-Idiotypic Antibodies
Neoplasms
Cardiovascular Diseases
Ischemia
Guidelines
Transplants
Kidney
Education

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Management of patients on the waiting list for deceased donor kidney transplantation. / Kim, Myung-Gyu; Ro, H.; Kim, Y. J.; Park, H. C.; Jeong, J. C.; Jeon, H. J.; Kim, H.; Park, M. W.; Oh, K. H.; Kim, Y. S.; Ahn, C.; Yang, J.

In: Transplantation Proceedings, Vol. 44, No. 1, 01.01.2012, p. 66-71.

Research output: Contribution to journalArticle

Kim, M-G, Ro, H, Kim, YJ, Park, HC, Jeong, JC, Jeon, HJ, Kim, H, Park, MW, Oh, KH, Kim, YS, Ahn, C & Yang, J 2012, 'Management of patients on the waiting list for deceased donor kidney transplantation', Transplantation Proceedings, vol. 44, no. 1, pp. 66-71. https://doi.org/10.1016/j.transproceed.2011.12.020
Kim, Myung-Gyu ; Ro, H. ; Kim, Y. J. ; Park, H. C. ; Jeong, J. C. ; Jeon, H. J. ; Kim, H. ; Park, M. W. ; Oh, K. H. ; Kim, Y. S. ; Ahn, C. ; Yang, J. / Management of patients on the waiting list for deceased donor kidney transplantation. In: Transplantation Proceedings. 2012 ; Vol. 44, No. 1. pp. 66-71.
@article{596d421683c74d169807c05ead9085f3,
title = "Management of patients on the waiting list for deceased donor kidney transplantation",
abstract = "Background: Although the number of wait-listed patients for deceased donor kidney transplantation has been continuously increasing in Korea, no standard guidelines exist for their management. Methods: We retrospectively analyzed the medical records of our 1,231 wait-listed patients between 2000 and 2010. Results: The time to transplantation of the 201 recipients was 51.9 ± 31.2 months. Ninety-seven patients died while waiting. Diabetic or older patients have increased among new registrants; however, <50{\%} of them have undergone regular screening for malignancy or cardiovascular diseases. Patients with regular screening were more likely to get a chance to receive a transplant (P =.016). Malignancy was newly diagnosed in 26 patients (2.1{\%}) and reversible cardiac ischemia was detected in 9.7{\%}. The presence of anti-HLA antibodies was strongly associated with a lower transplantation rate, whereas blood type O was not. Although use of expanded criteria donor (ECD) kidneys increased, many patients avoided them. Conclusion: It is necessary to improve management programs for wait-listed patients by establishing comorbidity screening and ECD education.",
author = "Myung-Gyu Kim and H. Ro and Kim, {Y. J.} and Park, {H. C.} and Jeong, {J. C.} and Jeon, {H. J.} and H. Kim and Park, {M. W.} and Oh, {K. H.} and Kim, {Y. S.} and C. Ahn and J. Yang",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.transproceed.2011.12.020",
language = "English",
volume = "44",
pages = "66--71",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Management of patients on the waiting list for deceased donor kidney transplantation

AU - Kim, Myung-Gyu

AU - Ro, H.

AU - Kim, Y. J.

AU - Park, H. C.

AU - Jeong, J. C.

AU - Jeon, H. J.

AU - Kim, H.

AU - Park, M. W.

AU - Oh, K. H.

AU - Kim, Y. S.

AU - Ahn, C.

AU - Yang, J.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background: Although the number of wait-listed patients for deceased donor kidney transplantation has been continuously increasing in Korea, no standard guidelines exist for their management. Methods: We retrospectively analyzed the medical records of our 1,231 wait-listed patients between 2000 and 2010. Results: The time to transplantation of the 201 recipients was 51.9 ± 31.2 months. Ninety-seven patients died while waiting. Diabetic or older patients have increased among new registrants; however, <50% of them have undergone regular screening for malignancy or cardiovascular diseases. Patients with regular screening were more likely to get a chance to receive a transplant (P =.016). Malignancy was newly diagnosed in 26 patients (2.1%) and reversible cardiac ischemia was detected in 9.7%. The presence of anti-HLA antibodies was strongly associated with a lower transplantation rate, whereas blood type O was not. Although use of expanded criteria donor (ECD) kidneys increased, many patients avoided them. Conclusion: It is necessary to improve management programs for wait-listed patients by establishing comorbidity screening and ECD education.

AB - Background: Although the number of wait-listed patients for deceased donor kidney transplantation has been continuously increasing in Korea, no standard guidelines exist for their management. Methods: We retrospectively analyzed the medical records of our 1,231 wait-listed patients between 2000 and 2010. Results: The time to transplantation of the 201 recipients was 51.9 ± 31.2 months. Ninety-seven patients died while waiting. Diabetic or older patients have increased among new registrants; however, <50% of them have undergone regular screening for malignancy or cardiovascular diseases. Patients with regular screening were more likely to get a chance to receive a transplant (P =.016). Malignancy was newly diagnosed in 26 patients (2.1%) and reversible cardiac ischemia was detected in 9.7%. The presence of anti-HLA antibodies was strongly associated with a lower transplantation rate, whereas blood type O was not. Although use of expanded criteria donor (ECD) kidneys increased, many patients avoided them. Conclusion: It is necessary to improve management programs for wait-listed patients by establishing comorbidity screening and ECD education.

UR - http://www.scopus.com/inward/record.url?scp=84863385635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863385635&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2011.12.020

DO - 10.1016/j.transproceed.2011.12.020

M3 - Article

VL - 44

SP - 66

EP - 71

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 1

ER -